Arrowhead Research Corporation News Headlines

ARWR 
$6.53
*  
0.10
1.56%
Get ARWR Alerts
*Delayed - data as of Jan. 26, 2015 11:17 ET  -  Find a broker to begin trading ARWR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ARWR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Seeking Alpha's Biotech Weekly: Roche Takes Control, Shire's A Buyer, And More
1/16/2015 4:00:00 PM - Seeking Alpha


Why Shares of Arrowhead Research Corp Imploded Today
1/12/2015 2:09:02 PM - Motley Fool


Mid-Day Market Update: Foundation Medicine Shares Jump Following Deal With Roche; Crude Oil Slides Over 4%
1/12/2015 12:55:56 PM - Benzinga


Mid-Morning Market Update: Markets Tumble; Shire To Acquire NPS Pharmaceuticals For $5.2 Billion
1/12/2015 11:37:57 AM - Benzinga


Arrowhead Research (ARWR) Stock Plummets Today After FDA Partial Clinical Hold
1/12/2015 10:16:00 AM - TheStreet


Tekmira/Oncore Merger Represents Substantial Upside
1/12/2015 8:49:00 AM - Seeking Alpha


Arrowhead Reports Partial Clinical Hold For ARC-50 Phase 2b Study - Quick Facts
1/12/2015 7:23:00 AM - RTT News


Assessing Gilead's Reality-Perception Gap: Upside Revenue Surprise
1/6/2015 2:32:00 PM - Seeking Alpha


Which Biotech Will Become the Next Gilead Sciences, Inc.?
12/16/2014 9:03:02 AM - Motley Fool


Health Care Sector Update for 11/26/2014: ARWR, AMGN, AZN
11/26/2014 8:43:52 AM - MT Newswires


Earnings Reaction History: Arrowhead Research Corp., 50.0% Follow-Through Indicator, 3.8% Sensitive
11/25/2014 3:08:11 PM - MT Newswires


Arrowhead Research Q4 14 Earnings Conference Call At 4:30 PM ET
11/25/2014 3:02:00 PM - RTT News


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 11:40:00 AM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game-Changer
11/25/2014 10:30:00 AM - Seeking Alpha


Marina Biotech: A Forgotten And Grossly Undervalued Game Changer
11/25/2014 10:30:00 AM - SeekingAlpha


After Hours Most Active for Nov 7, 2014 : F, GLW, MON, MRK, BTU, ORCL, SIRI, AAPL, MU, PPC, ARWR, ODP
11/7/2014 4:44:05 PM - NASDAQ.com News


Can Arrowhead Research Corp. Stock Recover from Its Horrendous Drop?
10/9/2014 4:09:02 PM - Motley Fool


Arrowhead explains the ARC-520 data
10/9/2014 9:18:00 AM - Seeking Alpha


Sector Update: Health Care Stocks End With Out-Sized Gains; Arrowhead Research Shot Down After Trial Data Lags Expectations
10/8/2014 3:01:30 PM - MT Newswires


Sector Update: Health Care
10/8/2014 3:00:03 PM - MT Newswires


If Gilead's Hepatitis C Treatment Grosses $10B+ Per Year, Arrowhead's Hepatitis B Treatment Is Attractive.
10/6/2014 11:57:00 AM - Seeking Alpha


Ocera Therapeutics Finally Ready To Reward Investors
10/1/2014 12:32:00 PM - Seeking Alpha


Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14)
9/12/2014 5:47:00 AM - Seeking Alpha


Incyte Pharmaceutical: Top Idea For 2H14 With 2 Free Call Options Driving M&A Valuation To $93, Gilead Most Likely Suitor
9/11/2014 10:49:00 AM - Seeking Alpha


Friday's ETF Movers: XBI, PIZ
8/29/2014 11:57:06 AM - BNK Invest